Intrapleural use of tissue plasminogen activator and DNase in pleural infection
BACKGROUND: More than 30% of patients with pleural infection either die or require surgery. Drainage of infected fluid is key to successful treatment, but intrapleural fibrinolytic therapy did not improve outcomes in an earlier, large, randomized trial. METHODS: We conducted a blinded, 2-by-2 factor...
Egile Nagusiak: | Rahman, N, Maskell, N, West, A, Teoh, R, Arnold, A, Mackinlay, C, Peckham, D, Davies, C, Ali, N, Kinnear, W, Bentley, A, Kahan, B, Wrightson, J, Davies, H, Hooper, C, Lee, Y, Hedley, E, Crosthwaite, N, Choo, L, Helm, E, Gleeson, F, Nunn, A, Davies, R |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2011
|
Antzeko izenburuak
-
Intrapleural use of tissue plasminogen activator and DNase in pleural infection.
nork: Rahman, N, et al.
Argitaratua: (2011) -
PRIMARY RESULT OF THE SECOND MULTICENTRE INTRAPLEURAL SEPSIS (MIST2) TRIAL; RANDOMISED TRIAL OF INTRAPLEURAL TPA AND DNASE IN PLEURAL INFECTION
nork: Rahman, N, et al.
Argitaratua: (2009) -
The biological effect of tissue plasminogen (t-PA) activator and DNase intrapleural delivery in pleural infection patients
nork: Kanellakis, N, et al.
Argitaratua: (2018) -
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients
nork: Kanellakis, N, et al.
Argitaratua: (2019) -
Intrapleural streptokinase for pleural infection.
nork: Maskell, N, et al.
Argitaratua: (2006)